VolitionRx Limited Tax Withholding Paid on Stock Awards
VolitionRx Limited (VNRX) reported Tax Withholding Paid on Stock Awards of $15.83 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-13
- VolitionRx Limited payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $125.00, a 99.77% decline year-over-year.
- VolitionRx Limited payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $15.71K, a 35.66% decline year-over-year.
- VolitionRx Limited payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $50.19K, a 39.40% decline year-over-year.
- VolitionRx Limited payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $80.38K, a 406.82% increase year-over-year.
- VolitionRx Limited payment, tax withholding, share-based payment arrangement for fiscal 2025 was $210.03K, a 50.09% increase from fiscal 2024.
- VolitionRx Limited payment, tax withholding, share-based payment arrangement for fiscal 2024 was $139.94K, a 31.36% decline from fiscal 2023.
- VolitionRx Limited payment, tax withholding, share-based payment arrangement for fiscal 2023 was $203.88K, a 12.97% increase from fiscal 2022.
- VolitionRx Limited payment, tax withholding, share-based payment arrangement for fiscal 2022 was $180.47K, a 38.37% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $125.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $15.83K 10-Q · filed 2026-08-13 | $66.02K derived: sum of 3 quarters · filed 2026-08-13 | $146.40K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $15.71K 10-Q · filed 2026-05-14 | $65.89K derived: sum of 2 quarters · filed 2026-05-14 | $146.27K derived: sum of 3 quarters · filed 2026-05-14 | $201.33K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $50.19K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $130.57K derived: sum of 2 quarters · filed 2026-03-31 | $185.62K derived: sum of 3 quarters · filed 2026-08-13 | $210.03K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $80.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $135.44K derived: sum of 2 quarters · filed 2026-08-13 | $159.85K 10-Q · filed 2025-11-13 | $242.66K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $55.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $79.47K 10-Q · filed 2026-08-13 | $162.28K derived: sum of 3 quarters · filed 2026-08-13 | $178.14K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $24.41K 10-Q · filed 2026-05-14 | $107.22K derived: sum of 2 quarters · filed 2026-05-14 | $123.08K derived: sum of 3 quarters · filed 2026-05-14 | $161.29K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $82.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $98.67K derived: sum of 2 quarters · filed 2026-03-31 | $136.88K derived: sum of 3 quarters · filed 2026-03-31 | $139.94K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $15.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $54.06K derived: sum of 2 quarters · filed 2025-11-13 | $57.13K 10-Q · filed 2025-11-13 | $180.77K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $38.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $41.27K 10-Q · filed 2025-08-14 | $164.91K derived: sum of 3 quarters · filed 2025-08-14 | $164.91K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $3.06K 10-Q · filed 2025-05-15 | $126.71K derived: sum of 2 quarters · filed 2025-05-15 | $126.71K derived: sum of 3 quarters · filed 2025-05-15 | $192.60K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $123.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $123.65K derived: sum of 2 quarters · filed 2025-03-31 | $189.54K derived: sum of 3 quarters · filed 2025-03-31 | $203.88K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $65.89K derived: sum of 2 quarters · filed 2024-11-14 | $80.23K 10-Q · filed 2024-11-14 | $153.30K 10-Q · filed 2023-11-14 | $110.43K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $65.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $80.23K 10-Q · filed 2024-08-14 | $110.43K derived: sum of 3 quarters · filed 2024-08-14 | $192.72K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $14.34K 10-Q · filed 2024-05-13 | $44.53K derived: sum of 2 quarters · filed 2024-05-13 | $126.82K derived: sum of 3 quarters · filed 2024-05-13 | $194.81K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $30.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $112.48K derived: sum of 2 quarters · filed 2024-03-25 | $180.47K derived: sum of 3 quarters · filed 2024-03-25 | $180.47K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $82.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $150.28K derived: sum of 2 quarters · filed 2023-11-14 | $150.28K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $67.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $67.99K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | $130.43K 10-K · filed 2022-03-30 | ||||
| 2020-12-31 | $187.47K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |